|
Aug 28
|
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
|
|
May 15
|
Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
Apr 8
|
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
|
|
Mar 25
|
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
|
|
Mar 22
|
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
|
|
Jan 8
|
Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
|
|
Jan 8
|
Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization
|
|
Dec 21
|
Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”
|
|
Aug 25
|
Marker Therapeutics Inc's Uncertain Future: Understanding the Barriers to Outperformance
|